QOP
EVH icon

Quinn Opportunity Partners’s Evolent Health EVH Stock Holding History

Quinn Opportunity Partners’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$540K Hold
99,687
– – 0.03% 268
2026
Q1 		$227K Hold
99,687
– – 0.01% 310
2025
Q4 		$399K Sell
99,687
-20,313
-17% -$113K 0.02% 299
2025
Q3 		$1.02M Hold
120,000
– – 0.07% 184
2025
Q2 		$1.35M Hold
120,000
– – 0.11% 163
2025
Q1 		$1.14M Buy
120,000
+30,000
+33% +$303K 0.08% 202
2024
Q4 		$1.01M Buy
+90,000
New +$1.58M 0.07% 200

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Quinn Opportunity Partners's EVH Position: Q2 2026 in Review

Quinn Opportunity Partners held its Evolent Health (EVH) position steady in Q2 2026 at 99,687 shares worth $540K. The position accounts for 0.03% of the portfolio, ranked #268.

Quinn Opportunity Partners first reported a position in EVH in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.35M in Q2 2025. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Quinn Opportunity Partners held 99,687 shares of Evolent Health worth $540K as of Q2 2026.
  • Quinn Opportunity Partners left its Evolent Health share count unchanged in Q2 2026.
  • Evolent Health made up 0.03% of Quinn Opportunity Partners's portfolio in Q2 2026, its #268 holding.
  • Quinn Opportunity Partners first reported a position in Evolent Health in Q4 2024 and has held it in 7 quarters since.
  • Quinn Opportunity Partners's Evolent Health position peaked at $1.35M in Q2 2025.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.